Significant association of anti-platelet factor 4/heparin antibody with cardiovascular disease in hemodialysis patients: a longitudinal 7-year study.
Chi-Chu LiuLi-Ping ChouTsang-Shan ChenChien-An ChenYueh-Feng TsaiPublished in: International urology and nephrology (2018)
This study reveals that PF4-H Ab is a risk factor for developing CAD, IS, and AVFT among hemodialysis patients.